The new WHO classification for acute myeloid leukemias and myelodysplastic syndromes:: Is it better than the FAB system?

被引：0
|
作者：
Löffler, H [1 ]
Haferlach, T [1 ]
机构：
[1] Univ Munich, Grosshaden, Med Klin & Poliklin 3, Munich, Germany
来源：
MEDIZINISCHE WELT | 2000年 / 51卷 / 11期
关键词：
acute myeloid leukemia; prognosis; cytomorphology; cytogenetic; WHO-classification;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Since 25 years the FAB (French-American-British) classification was used for acute myeloid leukemias (AML) and myelodysplastic syndromes (MDS). Now the WHO published a new proposal that is primary hosed on cytogenetic and molecular markers. In parallel, the history of the AML evolving from on MDS or therapy-related is taken into account. Dysplastic features ore also analyzed for further categories. The blast count for AML is newly defined to be more than 20%. This WHO proposal points out in the light direction. Its value for therapy, prognosis and its clinial relevance for a single patient has to be investigated prospectively.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [41] Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases
    Orazi, Attilio
    PATHOBIOLOGY, 2007, 74 (02) : 97 - 114
  • [42] PROGNOSTIC VALUE OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
    AUL, C
    FISCHER, JT
    HORSTKOTTE, D
    SCHNEIDER, W
    BLUT, 1984, 49 (03): : 246 - 246
  • [43] Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms
    Bennett, John M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (11): : 607 - 609
  • [44] ACUTE LEUKEMIAS - FAB CLASSIFICATION AND CLINICAL CORRELATES
    LAUGHLIN, WR
    BICK, RL
    LABORATORY MEDICINE, 1994, 25 (01) : 11 - 16
  • [45] CHROMOSOMAL STUDIES IN 24 PATIENTS WITH SECONDARY ACUTE MYELOID LEUKEMIAS (AML) AND MYELODYSPLASTIC SYNDROMES (MDS)
    WEH, HJ
    HOFFMANN, R
    SUCIU, S
    KUSE, R
    HOSSFELD, DK
    BLUT, 1987, 55 (04): : 236 - 236
  • [46] Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine
    María Abáigar
    Fernando Ramos
    Rocío Benito
    María Díez-Campelo
    Javier Sánchez-del-Real
    Lourdes Hermosín
    Juan Nicolás Rodríguez
    Carlos Aguilar
    Isabel Recio
    Jose María Alonso
    Natalia de las Heras
    Marta Megido
    Marta Fuertes
    María Consuelo del Cañizo
    Jesús María Hernández-Rivas
    Annals of Hematology, 2013, 92 : 1543 - 1552
  • [47] Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukemias and myelodysplastic syndromes
    Invernizzi, R.
    Travaglino, E.
    Benatti, C.
    Malcovati, L.
    Della Porta, M. G.
    Cazzola, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 79 - 80
  • [48] Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias
    Dunphy, Cherie H.
    O'Malley, Dennis P.
    Perkins, Sherrie L.
    Chang, Chung-Che
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (02): : 154 - 159
  • [49] Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias
    Popp, Henning D.
    Naumann, Nicole
    Brendel, Susanne
    Henzler, Thomas
    Weiss, Christel
    Hofmann, Wolf-Karsten
    Fabarius, Alice
    LEUKEMIA RESEARCH, 2017, 57 : 112 - 118
  • [50] Imaging Mass Cytometry Reveals the Spatial Architecture of Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemias
    Oetjen, Karolyn A.
    Bender, Diane E.
    Ruzinova, Marianna B.
    Fisher, Daniel A. C.
    Oh, Stephen T.
    Link, Daniel C.
    BLOOD, 2020, 136
12345